What’s new in oncology: Breast Cancer

    

What's new in oncology  (UpToDate – you *may* need to be logged into UpToDate before accessing these links. You can access via Zenworks (on a Trust computer) and then register for your own account which enables you to use the app and collect CPD points)

Authors: April F Eichler, MD, MPH, Diane MF Savarese, MD, Sadhna R Vora, MD

Literature review current through: Nov 2018. | This topic last updated: Dec 12, 2018.

Atezolizumab and nab-paclitaxel in triple negative breast cancer (November 2018)

Overall survival with fulvestrant and palbociclib in advanced HR-positive, HER2-negative breast cancer (November 2018)

  

Aromatase inhibitor-induced joint pain and acupuncture (July 2018)

Updated guidelines on HER2 ISH interpretation in breast cancer (July 2018) 

Avoidance of adjuvant chemotherapy in women with HR-positive, node-negative breast cancer and intermediate Recurrence Score (RS) (July 2018) 

Duration of adjuvant trastuzumab in early HER2-positive breast cancer (July 2018)

 Ovarian suppression with either tamoxifen or an aromatase inhibitor in premenopausal women with early breast cancer (July 2018)

Mixed data regarding denosumab as adjuvant breast cancer treatment (July 2018)

Addition of carboplatin to neoadjuvant chemotherapy for triple negative breast cancer (May 2018)